Semaglutide, the active ingredient in Ozempic and Wegovy, is a groundbreaking drug primarily used for managing type 2 diabetes and assisting with weight loss
Some clinicians argue that patients who have previously tolerated a medication can restart at a higher dose rather than the absolute minimum
Research suggests it is four times more effective than all the other treatment options combined [2]
With roughly two-thirds of Americans overweight, and one out of three obese, this class of drugs has understandably generated a lot of interest whether its people hailing their impact on weight loss, or voicing concerns about their side effects
Cook S, Togni M, Schaub MC, Wenaweser P, Hess OM
Evans MC, Couch Y, Sibson N, Turner MR